scispace - formally typeset
J

Jean-Marie Darbon

Researcher at French Institute of Health and Medical Research

Publications -  40
Citations -  1295

Jean-Marie Darbon is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Protein kinase C & Protein phosphorylation. The author has an hindex of 19, co-authored 40 publications receiving 1263 citations.

Papers
More filters
Journal ArticleDOI

CIP2A Is Associated with Human Breast Cancer Aggressivity

TL;DR: The data show that CIP2A is associated with clinical aggressivity in human breast cancer and promotes the malignant growth of breast cancer cells.
Journal ArticleDOI

A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer

TL;DR: A molecular signature specifying a subgroup of patients who do not gain benefits from tamoxifen treatment is identified and these patients may therefore be eligible for alternative endocrine therapies and/or chemotherapy.
Journal Article

Inhibition of MCF-7 cell growth by 12-O-tetradecanoylphorbol-13-acetate and 1,2-dioctanoyl-sn-glycerol: distinct effects on protein kinase C activity.

TL;DR: The results reinforce the hypothesis of a negative modulatory role of protein kinase C in MCF-7 cell proliferation but suggest that the two activators TPA and DiC8 could induce distinct molecular events with regard to the enzyme recruitment and activity as well as to its further processing.
Journal ArticleDOI

G1 phase arrest by the phosphatidylinositol 3-kinase inhibitor LY 294002 is correlated to up-regulation of p27Kip1 and inhibition of G1 CDKs in choroidal melanoma cells

TL;DR: It is reported that the LY 294002‐induced G1 arrest is closely correlated to inhibition of CDK4 and CDK2 activities leading to the impairment of pRb phosphorylation which normally occurs during G1 progression.
Journal ArticleDOI

Tumor necrosis factor-α inhibits follicle-stimulating hormone-induced differentiation in cultured rat granulosa cells

TL;DR: TNF-α may drastically reduce the capacity of granulosa cells to differentiate upon FSH stimulation and to respond to LH during the physiological ovarian follicular maturation, suggesting that anti-gonadotropic action of TNF-β may be also relevant to the alteration of ovarian function during physiopathological processes like inflammatory or infection diseases.